According to the results of this study, four hub genes (CXCL10, GZMA, ITGA4 and PSMB9) could be used to determine disease activity in patients with RA and pSS, and these genes might provide insight into the common mechanisms underlying the two diseases. This evidence concerns the gene PSMB9 and peeling skin syndrome.